Stay updated on Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.

Latest updates to the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page
- Check4 days agoChange DetectedThe revision label was updated from v3.5.4 to v3.5.5, signaling a small maintenance update to the page version history.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page's revision tag was updated to v3.5.4, replacing the previous v3.5.3.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page’s revision/version label in the footer was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision banner updated from v3.5.0 to v3.5.2; the old v3.5.0 label was removed.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision history updated: a new version v3.5.0 is now listed, replacing the previous v3.4.3.SummaryDifference0.1%

- Check89 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.